Grayson I. Dimick
Subscribe to Grayson I. Dimick's PostsGrayson I. Dimick focuses her practice on regulatory and transactional matters affecting a wide range of clients across the health care industry. Grayson advises clients on a variety of issues, including the regulatory and compliance aspects of digital health. She also conducts due diligence on health care transactions. Read Grayson Dimick's full bio.
DEA Further Extends Flexibilities for Controlled-Substance Prescribing via Telemedicine
By Amanda Enyeart, Marshall E. Jackson, Jr., Lisa Schmitz Mazur, Dale C. Van Demark, Patrick Zanayed, Purnima Boominathan, Grayson I. Dimick, Jayda Greco and Rachel Stauffer on Oct 25, 2023
Posted In Employee Benefits, Health and Welfare Plans
The US Drug Enforcement Administration and the Substance Abuse and Mental Health Services Administration have further extended flexibilities that allow providers to prescribe controlled substances via telemedicine without first performing an in-person visit. The flexibilities were initially provided during the COVID-19 public health emergency. The extension runs through December 31, 2024. Read more here.
Continue Reading
New York Proposes Regulations Expanding State’s Ability to Regulate PBMs
By Gregory Mitchell, Grayson I. Dimick and Benjamin Glass on Oct 3, 2023
Posted In Employee Benefits, Health and Welfare Plans
Continue Reading
July Trending in Telehealth
By Dale C. Van Demark and Grayson I. Dimick on Aug 2, 2023
Posted In Digital Health, Employee Benefits, Health and Welfare Plans
Numerous states—including Alaska, Maryland, California and Colorado—have been busy finalizing rulemaking and legislation impacting Medicaid coverage and maternal health. What have these states been up to over the last month? Learn more here.
Continue Reading
Teleprescribing of Controlled Substances Temporarily Extended Beyond PHE
By Lisa Schmitz Mazur, Rachel Stauffer, Amanda Enyeart, Jayda Greco, Marika Miller, Grayson I. Dimick, Moyosore Koya, Marshall E. Jackson, Jr., Dale C. Van Demark and Patrick Zanayed on Jun 23, 2023
Posted In Digital Health, Employee Benefits, Health and Welfare Plans
The US Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) are extending telehealth flexibilities that allow providers to prescribe controlled substances. While the extension is in place, the DEA indicated that it will be further evaluating its recently proposed rules for post-COVID-19 public health emergency telemedicine prescription of controlled...
Continue Reading
CMS Issues Broad-Ranging Medicare Advantage and Part D Proposed Rule
By Ankur J. Goel, Emily Curran, Grayson I. Dimick and Casey Li on Feb 21, 2023
Posted In Employee Benefits, Health and Welfare Plans
The Centers for Medicare & Medicaid Services (CMS) recently issued a proposed rule regarding Contract Year 2024 Policy and Technical Changes to the Medicare Advantage (MA) and Medicare Prescription Drug Benefit Programs. This proposed rule includes a range of proposals addressing popular topics, including marketing and prior authorization, along with other significant changes to utilization...
Continue Reading
Omnibus Bill Extends Medicare Telehealth Flexibilities and HDHP Telehealth Safe Harbor
By Amanda Enyeart, Marshall E. Jackson, Jr., Lisa Schmitz Mazur, Rachel Stauffer, Grayson I. Dimick, Jayda Greco, Abby Higgins, Ashley Ogedegbe and Sarah Raaii on Dec 28, 2022
Posted In Digital Health, Employee Benefits, Health and Welfare Plans
On December 23, 2022, US Congress approved a year-end omnibus legislative package, Consolidated Appropriations Act, 2023 (CAA 2023), which consists of all 12 fiscal year 2023 appropriations bills and numerous other provisions, including health policy changes. The healthcare provisions in this omnibus package extend key Medicare telehealth flexibilities and the temporary telehealth safe harbor for...
Continue Reading
